speb/financial-data huggingface dataset:
UVE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 26670000.00
UVE balance_sheet (quarterly, 2025-03-31) — Share Issued: 47572000.00
UVE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 422387000.00
UVE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 422387000.00
UVE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (quarterly, 2025-03-31) — Tax Provision: 14017000.00
UVE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
UVE balance_sheet (quarterly, 2025-03-31) — Total Assets: 2714716000.00
UVE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 523440000.00
UVE balance_sheet (quarterly, 2025-03-31) — Total Debt: 101053000.00
UVE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 422387000.00
UVE income_statement (quarterly, 2025-03-31) — Total Expenses: 339411000.00
UVE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2292329000.00
UVE income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 177000.00
UVE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 28567000.00
UVE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 19382000.00
UVE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 282693000.00
UVE income_statement (quarterly, 2025-06-30) — +Total Revenue: 400141000.00
UVE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 709453000.00
UVE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 465582000.00
UVE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 123919000.00
UVE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 27972000.00
UVE income_statement (quarterly, 2025-06-30) — Basic EPS: 1.25
UVE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 400819000.00
UVE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -977000.00
UVE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 476000.00
UVE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 367108000.00
UVE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 563406000.00
UVE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -4517000.00
UVE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -12335000.00
UVE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -58964000.00
UVE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 34924000.00
UVE balance_sheet (quarterly, 2025-06-30) — Common Stock: 476000.00
UVE cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -4515000.00
UVE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 457808000.00
UVE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -7427000.00
UVE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 29072000.00
UVE income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.21
UVE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 35091000.00
UVE income_statement (quarterly, 2025-06-30) — EBIT: 47817000.00
UVE cash_flow (quarterly, 2025-06-30) — End Cash Position: 435743000.00
UVE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -12335000.00
UVE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 105246000.00
UVE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -40782000.00
UVE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 29964000.00
UVE balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 0.00
UVE income_statement (quarterly, 2025-06-30) — Interest Expense: 1431000.00
UVE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1431000.00
UVE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 558670000.00
UVE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -58964000.00
UVE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1491827000.00
UVE balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 3932000.00
UVE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 100862000.00
UVE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 100862000.00
UVE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -368000.00
UVE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 3932000.00
UVE income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: 260305000.00
UVE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -7427000.00
UVE income_statement (quarterly, 2025-06-30) — Net Income: 35093000.00
UVE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 35091000.00
UVE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 35093000.00
UVE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 35093000.00
UVE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 35093000.00
UVE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 35093000.00
UVE income_statement (quarterly, 2025-06-30) — Net Interest Income: -1608000.00
UVE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -69453000.00
UVE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -368000.00
UVE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -368000.00
UVE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1608000.00
UVE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -23000.00
UVE balance_sheet (quarterly, 2025-06-30) — Net PPE: 47679000.00
UVE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -974000.00
UVE income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 260305000.00
UVE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 457808000.00
UVE income_statement (quarterly, 2025-06-30) — Normalized Income: 35093000.00
UVE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 106223000.00
UVE income_statement (quarterly, 2025-06-30) — Operating Revenue: 400141000.00
UVE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 27927000.00
UVE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -40782000.00
UVE income_statement (quarterly, 2025-06-30) — Other Gand A: 29964000.00
UVE income_statement (quarterly, 2025-06-30) — Other Income Expense: 2014000.00
UVE balance_sheet (quarterly, 2025-06-30) — Other Payable: 29383000.00
UVE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 196298000.00
UVE balance_sheet (quarterly, 2025-06-30) — Payables: 738836000.00
UVE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 738836000.00
UVE income_statement (quarterly, 2025-06-30) — Policyholder Benefits Ceded: 648000.00
UVE income_statement (quarterly, 2025-06-30) — Policyholder Benefits Gross: 260953000.00
UVE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
UVE cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -2000.00
UVE income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 2000.00
UVE balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 639022000.00
UVE income_statement (quarterly, 2025-06-30) — Pretax Income: 46386000.00
UVE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -151468000.00
UVE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -977000.00
UVE balance_sheet (quarterly, 2025-06-30) — Receivables: 474600000.00
UVE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -368000.00
UVE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -7427000.00
UVE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 664315000.00
UVE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 82015000.00
UVE cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 3000.00
UVE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 29964000.00
UVE balance_sheet (quarterly, 2025-06-30) — Share Issued: 47596000.00
UVE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 457808000.00
UVE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 457808000.00
UVE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (quarterly, 2025-06-30) — Tax Provision: 11293000.00
UVE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
UVE balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 9018000.00
UVE balance_sheet (quarterly, 2025-06-30) — Total Assets: 3275818000.00
UVE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 558670000.00
UVE balance_sheet (quarterly, 2025-06-30) — Total Debt: 100862000.00
UVE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 457808000.00
UVE income_statement (quarterly, 2025-06-30) — Total Expenses: 353755000.00
UVE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2818010000.00
UVE income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 177000.00
UVE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 0.00
UVE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 19669000.00
UVE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 290120000.00
UVE income_statement (quarterly, 2025-09-30) — +Total Revenue: 400981000.00
UVE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 501809000.00
UVE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 398362000.00
UVE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 124063000.00
UVE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 27851000.00
UVE income_statement (quarterly, 2025-09-30) — Basic EPS: 1.43
UVE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 435743000.00
UVE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1157000.00
UVE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 481000.00
UVE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 405114000.00
UVE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 571500000.00
UVE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -4460000.00
UVE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -15251000.00
UVE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -8689000.00
UVE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 38481000.00
UVE balance_sheet (quarterly, 2025-09-30) — Common Stock: 481000.00
UVE cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -4457000.00
UVE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 495043000.00
UVE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -8074000.00
UVE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 28808000.00
UVE income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.38
UVE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 39827000.00
UVE income_statement (quarterly, 2025-09-30) — EBIT: 54203000.00
UVE cash_flow (quarterly, 2025-09-30) — End Cash Position: 474224000.00
UVE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -15251000.00
UVE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 61264000.00
UVE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -30755000.00
UVE balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 3664000.00
UVE income_statement (quarterly, 2025-09-30) — Interest Expense: 1426000.00
UVE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1426000.00
UVE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 595714000.00
UVE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -8689000.00
UVE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 1513516000.00
UVE balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 3903000.00
UVE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 100671000.00
UVE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 100671000.00
UVE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -368000.00
UVE balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 3903000.00
UVE income_statement (quarterly, 2025-09-30) — Loss Adjustment Expense: 252279000.00
UVE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
UVE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -8074000.00
UVE income_statement (quarterly, 2025-09-30) — Net Income: 39830000.00
UVE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 39827000.00
UVE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 39830000.00
UVE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 39830000.00
UVE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 39830000.00
UVE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 39830000.00
UVE income_statement (quarterly, 2025-09-30) — Net Interest Income: -1603000.00
UVE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -7543000.00
UVE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -368000.00
UVE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -368000.00
UVE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1603000.00
UVE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2349000.00
UVE balance_sheet (quarterly, 2025-09-30) — Net PPE: 49931000.00
UVE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1146000.00
UVE income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 252279000.00
UVE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 495043000.00
UVE income_statement (quarterly, 2025-09-30) — Normalized Income: 39830000.00
UVE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 62421000.00
UVE income_statement (quarterly, 2025-09-30) — Operating Revenue: 400981000.00
UVE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 28048000.00
UVE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -30755000.00
UVE income_statement (quarterly, 2025-09-30) — Other Income Expense: 2030000.00
UVE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 30728000.00
UVE balance_sheet (quarterly, 2025-09-30) — Other Payable: 34795000.00
UVE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 166386000.00
UVE balance_sheet (quarterly, 2025-09-30) — Payables: 540268000.00
UVE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 540268000.00
UVE income_statement (quarterly, 2025-09-30) — Policyholder Benefits Ceded: 3886000.00
UVE income_statement (quarterly, 2025-09-30) — Policyholder Benefits Gross: 256165000.00
UVE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
UVE cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -3000.00
UVE income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 3000.00
UVE balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 465016000.00
UVE income_statement (quarterly, 2025-09-30) — Pretax Income: 52777000.00
UVE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -119676000.00
UVE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1157000.00
UVE balance_sheet (quarterly, 2025-09-30) — Receivables: 398362000.00
UVE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -368000.00
UVE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -8074000.00
UVE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 699448000.00
UVE cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
UVE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 112133000.00
UVE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 11000.00
UVE balance_sheet (quarterly, 2025-09-30) — Share Issued: 48064000.00
UVE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 495043000.00
UVE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 495043000.00
UVE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (quarterly, 2025-09-30) — Tax Provision: 12947000.00
UVE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
UVE balance_sheet (quarterly, 2025-09-30) — Total Assets: 3089645000.00
UVE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 595714000.00
UVE balance_sheet (quarterly, 2025-09-30) — Total Debt: 100671000.00
UVE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 495043000.00
UVE income_statement (quarterly, 2025-09-30) — Total Expenses: 348204000.00
UVE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2594602000.00
UVE income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 177000.00
UVE balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 3664000.00
UVE balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 20016000.00
UVE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 298194000.00
UVE income_statement (annual, 2025-12-31) — +Total Revenue: 1603915000.00
UVE income_statement (quarterly, 2025-12-31) — +Total Revenue: 407926000.00
UVE balance_sheet (annual, 2025-12-31) — Accounts Payable: 257242000.00
UVE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 257242000.00
UVE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 308639000.00
UVE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 308639000.00
UVE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 124319000.00
UVE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 124319000.00
UVE cash_flow (annual, 2025-12-31) — Amortization Of Securities: 624000.00
UVE income_statement (annual, 2025-12-31) — Basic Average Shares: 27890000.00
UVE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 27797000.00
UVE income_statement (annual, 2025-12-31) — Basic EPS: 6.56
UVE income_statement (quarterly, 2025-12-31) — Basic EPS: 2.40
UVE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 262076000.00
UVE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 474224000.00
UVE cash_flow (annual, 2025-12-31) — Capital Expenditure: -4438000.00
UVE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1077000.00
UVE balance_sheet (annual, 2025-12-31) — Capital Stock: 482000.00
UVE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 482000.00
UVE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 408868000.00
UVE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 408868000.00
UVE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 571786000.00
UVE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 571786000.00
UVE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -22175000.00
UVE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -8354000.00
UVE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -52123000.00
UVE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -18059000.00
UVE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -113608000.00
UVE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4407000.00
UVE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 381493000.00
UVE cash_flow (annual, 2025-12-31) — Change In Account Payable: 36915000.00
UVE cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 23103000.00
UVE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 4891000.00
UVE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -8947000.00
UVE cash_flow (annual, 2025-12-31) — Change In Payable: 60394000.00
UVE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 60394000.00
UVE cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -28315000.00
UVE cash_flow (annual, 2025-12-31) — Change In Receivables: 394780000.00
UVE cash_flow (annual, 2025-12-31) — Change In Tax Payable: 23103000.00
UVE cash_flow (annual, 2025-12-31) — Change In Working Capital: 181938000.00
UVE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 394780000.00
UVE cash_flow (annual, 2025-12-31) — Changes In Cash: 215762000.00
UVE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 3614000.00
UVE balance_sheet (annual, 2025-12-31) — Common Stock: 482000.00
UVE balance_sheet (quarterly, 2025-12-31) — Common Stock: 482000.00
UVE cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -22165000.00
UVE cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -8352000.00
UVE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 551035000.00
UVE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 551035000.00
UVE cash_flow (annual, 2025-12-31) — Common Stock Payments: -22370000.00
UVE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -6869000.00
UVE cash_flow (annual, 2025-12-31) — Deferred Income Tax: 2570000.00
UVE cash_flow (annual, 2025-12-31) — Deferred Tax: 2570000.00
UVE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 6444000.00
UVE income_statement (annual, 2025-12-31) — Diluted Average Shares: 28956000.00
UVE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 29161000.00
UVE income_statement (annual, 2025-12-31) — Diluted EPS: 6.32
UVE income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.28
UVE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 182941000.00
UVE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 66587000.00
UVE income_statement (annual, 2025-12-31) — EBIT: 248783000.00
UVE income_statement (quarterly, 2025-12-31) — EBIT: 89872000.00
UVE cash_flow (annual, 2025-12-31) — End Cash Position: 477838000.00
UVE cash_flow (quarterly, 2025-12-31) — End Cash Position: 477838000.00
UVE cash_flow (annual, 2025-12-31) — Excess Tax Benefit From Stock Based Compensation: -1109000.00
UVE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -52123000.00
UVE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -18059000.00
UVE cash_flow (annual, 2025-12-31) — Free Cash Flow: 377055000.00
UVE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 25003000.00
UVE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -6084000.00
UVE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 128000.00
UVE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -26151000.00
UVE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -26151000.00
UVE income_statement (annual, 2025-12-31) — General And Administrative Expense: 118300000.00
UVE cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 35556000.00
UVE balance_sheet (annual, 2025-12-31) — Income Tax Payable: 28554000.00
UVE balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 28554000.00
UVE income_statement (annual, 2025-12-31) — Interest Expense: 5714000.00
UVE income_statement (quarterly, 2025-12-31) — Interest Expense: 1422000.00
UVE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 5714000.00
UVE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1422000.00
UVE cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 5714000.00
UVE balance_sheet (annual, 2025-12-31) — Invested Capital: 651516000.00
UVE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 651516000.00
UVE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -113608000.00
UVE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4407000.00
UVE balance_sheet (annual, 2025-12-31) — Investments And Advances: 1527141000.00
UVE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1527141000.00
UVE balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 10693000.00
UVE balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 10693000.00
UVE balance_sheet (annual, 2025-12-31) — Long Term Debt: 100481000.00
UVE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 100481000.00
UVE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 100481000.00
UVE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 100481000.00
UVE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1471000.00
UVE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -368000.00
UVE balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 10693000.00
UVE balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 10693000.00
UVE income_statement (annual, 2025-12-31) — Loss Adjustment Expense: 985878000.00
UVE income_statement (quarterly, 2025-12-31) — Loss Adjustment Expense: 222739000.00
UVE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -22370000.00
UVE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -6869000.00
UVE income_statement (annual, 2025-12-31) — Net Income: 182951000.00
UVE income_statement (quarterly, 2025-12-31) — Net Income: 66589000.00
UVE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 182941000.00
UVE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 66587000.00
UVE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 182951000.00
UVE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 66589000.00
UVE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 182951000.00
UVE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 66589000.00
UVE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 182951000.00
UVE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 66589000.00
UVE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 182951000.00
UVE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 182951000.00
UVE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 66589000.00
UVE income_statement (annual, 2025-12-31) — Net Interest Income: -6422000.00
UVE income_statement (quarterly, 2025-12-31) — Net Interest Income: -1599000.00
UVE cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: 0.00
UVE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -109210000.00
UVE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 8116000.00
UVE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1471000.00
UVE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -368000.00
UVE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -1471000.00
UVE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -368000.00
UVE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -6422000.00
UVE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1599000.00
UVE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -6107000.00
UVE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -2468000.00
UVE balance_sheet (annual, 2025-12-31) — Net PPE: 49349000.00
UVE balance_sheet (quarterly, 2025-12-31) — Net PPE: 49349000.00
UVE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4398000.00
UVE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1060000.00
UVE income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 985878000.00
UVE income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 222739000.00
UVE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 551035000.00
UVE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 551035000.00
UVE income_statement (annual, 2025-12-31) — Normalized Income: 182951000.00
UVE income_statement (quarterly, 2025-12-31) — Normalized Income: 66589000.00
UVE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 381493000.00
UVE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 26080000.00
UVE cash_flow (annual, 2025-12-31) — Operating Gains Losses: -5956000.00
UVE income_statement (annual, 2025-12-31) — Operating Revenue: 1603915000.00
UVE income_statement (quarterly, 2025-12-31) — Operating Revenue: 407926000.00
UVE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 28008000.00
UVE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 28008000.00
UVE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -26151000.00
UVE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -26151000.00
UVE income_statement (annual, 2025-12-31) — Other Gand A: 118300000.00
UVE income_statement (annual, 2025-12-31) — Other Income Expense: 8316000.00
UVE income_statement (quarterly, 2025-12-31) — Other Income Expense: 1950000.00
UVE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3494000.00
UVE balance_sheet (annual, 2025-12-31) — Other Payable: 26307000.00
UVE balance_sheet (quarterly, 2025-12-31) — Other Payable: 26307000.00
UVE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 162918000.00
UVE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 162918000.00
UVE balance_sheet (annual, 2025-12-31) — Payables: 312103000.00
UVE balance_sheet (quarterly, 2025-12-31) — Payables: 312103000.00
UVE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 312103000.00
UVE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 312103000.00
UVE income_statement (annual, 2025-12-31) — Policyholder Benefits Ceded: 15391000.00
UVE income_statement (quarterly, 2025-12-31) — Policyholder Benefits Ceded: 11705000.00
UVE income_statement (annual, 2025-12-31) — Policyholder Benefits Gross: 1001269000.00
UVE income_statement (quarterly, 2025-12-31) — Policyholder Benefits Gross: 234444000.00
UVE balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
UVE balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
UVE cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -10000.00
UVE cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -2000.00
UVE income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 10000.00
UVE income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 2000.00
UVE balance_sheet (annual, 2025-12-31) — Prepaid Assets: 291031000.00
UVE balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 291031000.00
UVE income_statement (annual, 2025-12-31) — Pretax Income: 243069000.00
UVE income_statement (quarterly, 2025-12-31) — Pretax Income: 88450000.00
UVE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -460144000.00
UVE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -111985000.00
UVE cash_flow (annual, 2025-12-31) — Purchase Of Investment Properties: 0.00
UVE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4438000.00
UVE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1077000.00
UVE balance_sheet (annual, 2025-12-31) — Receivables: 308639000.00
UVE balance_sheet (quarterly, 2025-12-31) — Receivables: 308639000.00
UVE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 6444000.00
UVE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1471000.00
UVE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -368000.00
UVE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -22370000.00
UVE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -6869000.00
UVE balance_sheet (annual, 2025-12-31) — Retained Earnings: 757449000.00
UVE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 757449000.00
UVE cash_flow (annual, 2025-12-31) — Sale Of Investment: 350934000.00
UVE cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 120101000.00
UVE cash_flow (annual, 2025-12-31) — Sale Of PPE: 40000.00
UVE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 17000.00
UVE income_statement (annual, 2025-12-31) — Selling General And Administration: 118300000.00
UVE balance_sheet (annual, 2025-12-31) — Share Issued: 48234000.00
UVE balance_sheet (quarterly, 2025-12-31) — Share Issued: 48234000.00
UVE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 8652000.00
UVE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 551035000.00
UVE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 551035000.00
UVE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 551035000.00
UVE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 551035000.00
UVE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (annual, 2025-12-31) — Tax Provision: 60118000.00
UVE income_statement (quarterly, 2025-12-31) — Tax Provision: 21861000.00
UVE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
UVE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
UVE balance_sheet (annual, 2025-12-31) — Total Assets: 2839695000.00
UVE balance_sheet (quarterly, 2025-12-31) — Total Assets: 2839695000.00
UVE balance_sheet (annual, 2025-12-31) — Total Capitalization: 651516000.00
UVE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 651516000.00
UVE balance_sheet (annual, 2025-12-31) — Total Debt: 100481000.00
UVE balance_sheet (quarterly, 2025-12-31) — Total Debt: 100481000.00
UVE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 551035000.00
UVE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 551035000.00
UVE income_statement (annual, 2025-12-31) — Total Expenses: 1360846000.00
UVE income_statement (quarterly, 2025-12-31) — Total Expenses: 319476000.00
UVE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2288660000.00
UVE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2288660000.00
UVE income_statement (annual, 2025-12-31) — Total Other Finance Cost: 708000.00
UVE income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 177000.00
UVE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 28554000.00
UVE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 28554000.00
UVE balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 20226000.00
UVE balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 20226000.00
UVE balance_sheet (annual, 2025-12-31) — Treasury Stock: 305064000.00
UVE balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 305064000.00
UVE cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 1177000.00
UVE income_statement (quarterly, 2026-03-31) — +Total Revenue: 393565000.00
UVE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 135791000.00
UVE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 277883000.00
UVE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 123910000.00
UVE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 27651000.00
UVE income_statement (quarterly, 2026-03-31) — Basic EPS: 1.96
UVE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 477838000.00
UVE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1580000.00
UVE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 483000.00
UVE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 595771000.00
UVE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 740548000.00
UVE cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -4907000.00
UVE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -14138000.00
UVE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -20116000.00
UVE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 120568000.00
UVE balance_sheet (quarterly, 2026-03-31) — Common Stock: 483000.00
UVE cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -4904000.00
UVE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 584744000.00
UVE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -7149000.00
UVE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 28831000.00
UVE income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.88
UVE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 54288000.00
UVE income_statement (quarterly, 2026-03-31) — EBIT: 73110000.00
UVE cash_flow (quarterly, 2026-03-31) — End Cash Position: 598406000.00
UVE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -14138000.00
UVE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 153242000.00
UVE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -34516000.00
UVE balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 53614000.00
UVE income_statement (quarterly, 2026-03-31) — Interest Expense: 1418000.00
UVE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1418000.00
UVE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 685034000.00
UVE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -20116000.00
UVE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1531269000.00
UVE balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 10693000.00
UVE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 100290000.00
UVE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 100290000.00
UVE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -368000.00
UVE balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 10693000.00
UVE income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 228096000.00
UVE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -7149000.00
UVE income_statement (quarterly, 2026-03-31) — Net Income: 54291000.00
UVE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 54288000.00
UVE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 54291000.00
UVE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 54291000.00
UVE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 54291000.00
UVE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 54291000.00
UVE income_statement (quarterly, 2026-03-31) — Net Interest Income: -1595000.00
UVE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -18574000.00
UVE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -368000.00
UVE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -368000.00
UVE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1595000.00
UVE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1714000.00
UVE balance_sheet (quarterly, 2026-03-31) — Net PPE: 49346000.00
UVE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1542000.00
UVE income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 228096000.00
UVE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 584744000.00
UVE income_statement (quarterly, 2026-03-31) — Normalized Income: 54291000.00
UVE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 154822000.00
UVE income_statement (quarterly, 2026-03-31) — Operating Revenue: 393565000.00
UVE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 27905000.00
UVE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -34516000.00
UVE income_statement (quarterly, 2026-03-31) — Other Income Expense: 2060000.00
UVE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 27709000.00
UVE balance_sheet (quarterly, 2026-03-31) — Other Payable: 28260000.00
UVE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 144777000.00
UVE balance_sheet (quarterly, 2026-03-31) — Payables: 217665000.00
UVE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 217665000.00
UVE income_statement (quarterly, 2026-03-31) — Policyholder Benefits Ceded: 103000.00
UVE income_statement (quarterly, 2026-03-31) — Policyholder Benefits Gross: 228199000.00
UVE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
UVE cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -3000.00
UVE income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 3000.00
UVE balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 116996000.00
UVE income_statement (quarterly, 2026-03-31) — Pretax Income: 71692000.00
UVE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -130887000.00
UVE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1580000.00
UVE balance_sheet (quarterly, 2026-03-31) — Receivables: 277883000.00
UVE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -368000.00
UVE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -7149000.00
UVE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 807080000.00
UVE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 112313000.00
UVE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 38000.00
UVE balance_sheet (quarterly, 2026-03-31) — Share Issued: 48341000.00
UVE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 584744000.00
UVE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 584744000.00
UVE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
UVE income_statement (quarterly, 2026-03-31) — Tax Provision: 17401000.00
UVE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
UVE balance_sheet (quarterly, 2026-03-31) — Total Assets: 2769389000.00
UVE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 685034000.00
UVE balance_sheet (quarterly, 2026-03-31) — Total Debt: 100290000.00
UVE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 584744000.00
UVE income_statement (quarterly, 2026-03-31) — Total Expenses: 321873000.00
UVE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2184645000.00
UVE income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 177000.00
UVE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 53614000.00
UVE balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 20436000.00
UVE balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 312213000.00
UVE income_statement (quarterly, 2026-06-30) — Basic Average Shares: 27618000.00
UVE income_statement (quarterly, 2026-06-30) — Basic EPS: 2.14
UVE income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 29043000.00
UVE income_statement (quarterly, 2026-06-30) — Diluted EPS: 2.04
UVSP balance_sheet (annual, 2021-12-31) — Current Debt: 0.00
UVSP balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 0.00
UVSP cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 26589000.00
UVSP balance_sheet (annual, 2021-12-31) — Leases: 30407000.00
UVSP cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -3820000.00
UVSP cash_flow (annual, 2021-12-31) — Operating Gains Losses: -145000.00
UVSP balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 0.00
UVSP income_statement (annual, 2021-12-31) — Other Gand A: 12743000.00
UVSP income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 26000.00
UVSP cash_flow (annual, 2021-12-31) — Purchase Of Business: -3820000.00
UVSP income_statement (annual, 2022-12-31) — +Total Revenue: 296182000.00
UVSP balance_sheet (annual, 2022-12-31) — Accounts Payable: 14456000.00
UVSP balance_sheet (annual, 2022-12-31) — Accounts Receivable: 22463000.00
UVSP balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -47779000.00
UVSP balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 300808000.00
UVSP cash_flow (annual, 2022-12-31) — Amortization Cash Flow: -693000.00
UVSP cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: -693000.00
UVSP balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 2579000.00
UVSP income_statement (annual, 2022-12-31) — Basic Average Shares: 29392606.00
UVSP income_statement (annual, 2022-12-31) — Basic EPS: 2.66
UVSP cash_flow (annual, 2022-12-31) — Beginning Cash Position: 890150000.00
UVSP balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 51191000.00
UVSP cash_flow (annual, 2022-12-31) — Capital Expenditure: -5221000.00
UVSP balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 33153000.00
UVSP balance_sheet (annual, 2022-12-31) — Capital Stock: 157784000.00
UVSP balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 152799000.00
UVSP balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 152799000.00
UVSP cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -24607000.00
UVSP balance_sheet (annual, 2022-12-31) — Cash Financial: 84176000.00
UVSP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 50806000.00
UVSP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -897612000.00
UVSP cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 109455000.00
UVSP cash_flow (annual, 2022-12-31) — Change In Account Payable: 5993000.00
UVSP cash_flow (annual, 2022-12-31) — Change In Payable: 5993000.00
UVSP cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 5993000.00
UVSP cash_flow (annual, 2022-12-31) — Change In Receivables: -5859000.00
UVSP cash_flow (annual, 2022-12-31) — Change In Working Capital: 134000.00
UVSP cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -5859000.00
UVSP cash_flow (annual, 2022-12-31) — Changes In Cash: -737351000.00
UVSP balance_sheet (annual, 2022-12-31) — Common Stock: 157784000.00
UVSP cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -24607000.00
UVSP balance_sheet (annual, 2022-12-31) — Common Stock Equity: 776500000.00
UVSP cash_flow (annual, 2022-12-31) — Common Stock Issuance: 2541000.00
UVSP cash_flow (annual, 2022-12-31) — Common Stock Payments: -12284000.00
UVSP balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 21668000.00
UVSP balance_sheet (annual, 2022-12-31) — Current Debt: 125000000.00
UVSP balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 125000000.00
UVSP cash_flow (annual, 2022-12-31) — Deferred Income Tax: -545000.00
UVSP cash_flow (annual, 2022-12-31) — Deferred Tax: -545000.00
UVSP balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 0.00
UVSP cash_flow (annual, 2022-12-31) — Depreciation: 4465000.00
UVSP cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3772000.00
UVSP cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3772000.00
UVSP balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 9007000.00
UVSP income_statement (annual, 2022-12-31) — Diluted Average Shares: 29590909.00
UVSP income_statement (annual, 2022-12-31) — Diluted EPS: 2.64
UVSP income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 78120000.00
UVSP balance_sheet (annual, 2022-12-31) — Employee Benefits: 2950000.00
UVSP cash_flow (annual, 2022-12-31) — End Cash Position: 152799000.00
UVSP cash_flow (annual, 2022-12-31) — Financing Cash Flow: 50806000.00
UVSP cash_flow (annual, 2022-12-31) — Free Cash Flow: 104234000.00
UVSP cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -30000.00
UVSP income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 30000.00
UVSP balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -62104000.00
UVSP income_statement (annual, 2022-12-31) — General And Administrative Expense: 118881000.00
UVSP balance_sheet (annual, 2022-12-31) — Goodwill: 175510000.00
UVSP balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 186894000.00
UVSP balance_sheet (annual, 2022-12-31) — Gross PPE: 128777000.00
UVSP balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 154727000.00